The global market for mRNA Vaccines for Animals was valued at US$ 20.2 million in the year 2024 and is projected to reach a revised size of US$ 39.6 million by 2031, growing at a CAGR of 10.1% during the forecast period.

mRNA Vaccines for Animals Market

mRNA vaccines for animals are a type of veterinary vaccine that use messenger RNA (mRNA) technology to stimulate an immune response against specific pathogens in livestock, pets, and other animals. These vaccines work by delivering synthetic mRNA encoding viral or bacterial antigens into the animal’s cells, prompting the immune system to recognize and fight the targeted disease. Compared to traditional vaccines, mRNA vaccines offer faster development timelines, improved efficacy, and the ability to rapidly adapt to emerging animal diseases. They are being explored for various applications, including livestock diseases (such as foot-and-mouth disease), zoonotic infections, and companion animal health.

North American market for mRNA Vaccines for Animals is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for mRNA Vaccines for Animals is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of mRNA Vaccines for Animals include Ceva Animal Health, Merck Animal Health, Areterna, Bayer, BioNTech, Genvax Technologies, BioVenic, Moderna, Ruipu Biotechnology, Jinyu Bio-technology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for mRNA Vaccines for Animals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Vaccines for Animals.

The mRNA Vaccines for Animals market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global mRNA Vaccines for Animals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the mRNA Vaccines for Animals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of mRNA Vaccines for Animals Market Report

Report Metric	Details
Report Name	mRNA Vaccines for Animals Market
Accounted market size in year	US$ 20.2 million
Forecasted market size in 2031	US$ 39.6 million
CAGR	10.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Injectable Drug Administration Non-invasive Drug Administration
Segment by Application	for Poultry for Livestock Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Ceva Animal Health, Merck Animal Health, Areterna, Bayer, BioNTech, Genvax Technologies, BioVenic, Moderna, Ruipu Biotechnology, Jinyu Bio-technology, Shanghai Shen Lian Biomedical, Suzhou Kerui Meide Biomedical Technology, Shanghai Rnacure Biopharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of mRNA Vaccines for Animals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of mRNA Vaccines for Animals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is mRNA Vaccines for Animals Market growing?

Ans: The mRNA Vaccines for Animals Market witnessing a CAGR of 10.1% during the forecast period 2025-2031.

What is the mRNA Vaccines for Animals Market size in 2031?

Ans: The mRNA Vaccines for Animals Market size in 2031 will be US$ 39.6 million.

Who are the main players in the mRNA Vaccines for Animals Market report?

Ans: The main players in the mRNA Vaccines for Animals Market are Ceva Animal Health, Merck Animal Health, Areterna, Bayer, BioNTech, Genvax Technologies, BioVenic, Moderna, Ruipu Biotechnology, Jinyu Bio-technology, Shanghai Shen Lian Biomedical, Suzhou Kerui Meide Biomedical Technology, Shanghai Rnacure Biopharma

What are the Application segmentation covered in the mRNA Vaccines for Animals Market report?

Ans: The Applications covered in the mRNA Vaccines for Animals Market report are for Poultry, for Livestock, Others

What are the Type segmentation covered in the mRNA Vaccines for Animals Market report?

Ans: The Types covered in the mRNA Vaccines for Animals Market report are Injectable Drug Administration, Non-invasive Drug Administration

1 mRNA Vaccines for Animals Market Overview

1.1 Product Definition

1.2 mRNA Vaccines for Animals by Type

1.2.1 Global mRNA Vaccines for Animals Market Value Comparison by Type (2024 VS 2031)

1.2.2 Injectable Drug Administration

1.2.3 Non-invasive Drug Administration

1.3 mRNA Vaccines for Animals by Application

1.3.1 Global mRNA Vaccines for Animals Market Value by Application (2024 VS 2031)

1.3.2 for Poultry

1.3.3 for Livestock

1.3.4 Others

1.4 Global mRNA Vaccines for Animals Market Size Estimates and Forecasts

1.4.1 Global mRNA Vaccines for Animals Revenue 2020-2031

1.4.2 Global mRNA Vaccines for Animals Sales 2020-2031

1.4.3 Global mRNA Vaccines for Animals Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 mRNA Vaccines for Animals Market Competition by Manufacturers

2.1 Global mRNA Vaccines for Animals Sales Market Share by Manufacturers (2020-2025)

2.2 Global mRNA Vaccines for Animals Revenue Market Share by Manufacturers (2020-2025)

2.3 Global mRNA Vaccines for Animals Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of mRNA Vaccines for Animals, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of mRNA Vaccines for Animals, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of mRNA Vaccines for Animals, Product Type & Application

2.7 Global Key Manufacturers of mRNA Vaccines for Animals, Date of Enter into This Industry

2.8 Global mRNA Vaccines for Animals Market Competitive Situation and Trends

2.8.1 Global mRNA Vaccines for Animals Market Concentration Rate

2.8.2 The Global 5 and 10 Largest mRNA Vaccines for Animals Players Market Share by Revenue

2.8.3 Global mRNA Vaccines for Animals Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global mRNA Vaccines for Animals Market Scenario by Region

3.1 Global mRNA Vaccines for Animals Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global mRNA Vaccines for Animals Sales by Region: 2020-2031

3.2.1 Global mRNA Vaccines for Animals Sales by Region: 2020-2025

3.2.2 Global mRNA Vaccines for Animals Sales by Region: 2026-2031

3.3 Global mRNA Vaccines for Animals Revenue by Region: 2020-2031

3.3.1 Global mRNA Vaccines for Animals Revenue by Region: 2020-2025

3.3.2 Global mRNA Vaccines for Animals Revenue by Region: 2026-2031

3.4 North America mRNA Vaccines for Animals Market Facts & Figures by Country

3.4.1 North America mRNA Vaccines for Animals Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America mRNA Vaccines for Animals Sales by Country (2020-2031)

3.4.3 North America mRNA Vaccines for Animals Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe mRNA Vaccines for Animals Market Facts & Figures by Country

3.5.1 Europe mRNA Vaccines for Animals Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe mRNA Vaccines for Animals Sales by Country (2020-2031)

3.5.3 Europe mRNA Vaccines for Animals Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific mRNA Vaccines for Animals Market Facts & Figures by Region

3.6.1 Asia Pacific mRNA Vaccines for Animals Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific mRNA Vaccines for Animals Sales by Region (2020-2031)

3.6.3 Asia Pacific mRNA Vaccines for Animals Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America mRNA Vaccines for Animals Market Facts & Figures by Country

3.7.1 Latin America mRNA Vaccines for Animals Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America mRNA Vaccines for Animals Sales by Country (2020-2031)

3.7.3 Latin America mRNA Vaccines for Animals Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa mRNA Vaccines for Animals Market Facts & Figures by Country

3.8.1 Middle East and Africa mRNA Vaccines for Animals Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa mRNA Vaccines for Animals Sales by Country (2020-2031)

3.8.3 Middle East and Africa mRNA Vaccines for Animals Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global mRNA Vaccines for Animals Sales by Type (2020-2031)

4.1.1 Global mRNA Vaccines for Animals Sales by Type (2020-2025)

4.1.2 Global mRNA Vaccines for Animals Sales by Type (2026-2031)

4.1.3 Global mRNA Vaccines for Animals Sales Market Share by Type (2020-2031)

4.2 Global mRNA Vaccines for Animals Revenue by Type (2020-2031)

4.2.1 Global mRNA Vaccines for Animals Revenue by Type (2020-2025)

4.2.2 Global mRNA Vaccines for Animals Revenue by Type (2026-2031)

4.2.3 Global mRNA Vaccines for Animals Revenue Market Share by Type (2020-2031)

4.3 Global mRNA Vaccines for Animals Price by Type (2020-2031)

5 Segment by Application

5.1 Global mRNA Vaccines for Animals Sales by Application (2020-2031)

5.1.1 Global mRNA Vaccines for Animals Sales by Application (2020-2025)

5.1.2 Global mRNA Vaccines for Animals Sales by Application (2026-2031)

5.1.3 Global mRNA Vaccines for Animals Sales Market Share by Application (2020-2031)

5.2 Global mRNA Vaccines for Animals Revenue by Application (2020-2031)

5.2.1 Global mRNA Vaccines for Animals Revenue by Application (2020-2025)

5.2.2 Global mRNA Vaccines for Animals Revenue by Application (2026-2031)

5.2.3 Global mRNA Vaccines for Animals Revenue Market Share by Application (2020-2031)

5.3 Global mRNA Vaccines for Animals Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Ceva Animal Health

6.1.1 Ceva Animal Health Company Information

6.1.2 Ceva Animal Health Description and Business Overview

6.1.3 Ceva Animal Health mRNA Vaccines for Animals Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Ceva Animal Health mRNA Vaccines for Animals Product Portfolio

6.1.5 Ceva Animal Health Recent Developments/Updates

6.2 Merck Animal Health

6.2.1 Merck Animal Health Company Information

6.2.2 Merck Animal Health Description and Business Overview

6.2.3 Merck Animal Health mRNA Vaccines for Animals Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Merck Animal Health mRNA Vaccines for Animals Product Portfolio

6.2.5 Merck Animal Health Recent Developments/Updates

6.3 Areterna

6.3.1 Areterna Company Information

6.3.2 Areterna Description and Business Overview

6.3.3 Areterna mRNA Vaccines for Animals Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Areterna mRNA Vaccines for Animals Product Portfolio

6.3.5 Areterna Recent Developments/Updates

6.4 Bayer

6.4.1 Bayer Company Information

6.4.2 Bayer Description and Business Overview

6.4.3 Bayer mRNA Vaccines for Animals Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Bayer mRNA Vaccines for Animals Product Portfolio

6.4.5 Bayer Recent Developments/Updates

6.5 BioNTech

6.5.1 BioNTech Company Information

6.5.2 BioNTech Description and Business Overview

6.5.3 BioNTech mRNA Vaccines for Animals Sales, Revenue and Gross Margin (2020-2025)

6.5.4 BioNTech mRNA Vaccines for Animals Product Portfolio

6.5.5 BioNTech Recent Developments/Updates

6.6 Genvax Technologies

6.6.1 Genvax Technologies Company Information

6.6.2 Genvax Technologies Description and Business Overview

6.6.3 Genvax Technologies mRNA Vaccines for Animals Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Genvax Technologies mRNA Vaccines for Animals Product Portfolio

6.6.5 Genvax Technologies Recent Developments/Updates

6.7 BioVenic

6.7.1 BioVenic Company Information

6.7.2 BioVenic Description and Business Overview

6.7.3 BioVenic mRNA Vaccines for Animals Sales, Revenue and Gross Margin (2020-2025)

6.7.4 BioVenic mRNA Vaccines for Animals Product Portfolio

6.7.5 BioVenic Recent Developments/Updates

6.8 Moderna

6.8.1 Moderna Company Information

6.8.2 Moderna Description and Business Overview

6.8.3 Moderna mRNA Vaccines for Animals Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Moderna mRNA Vaccines for Animals Product Portfolio

6.8.5 Moderna Recent Developments/Updates

6.9 Ruipu Biotechnology

6.9.1 Ruipu Biotechnology Company Information

6.9.2 Ruipu Biotechnology Description and Business Overview

6.9.3 Ruipu Biotechnology mRNA Vaccines for Animals Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Ruipu Biotechnology mRNA Vaccines for Animals Product Portfolio

6.9.5 Ruipu Biotechnology Recent Developments/Updates

6.10 Jinyu Bio-technology

6.10.1 Jinyu Bio-technology Company Information

6.10.2 Jinyu Bio-technology Description and Business Overview

6.10.3 Jinyu Bio-technology mRNA Vaccines for Animals Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Jinyu Bio-technology mRNA Vaccines for Animals Product Portfolio

6.10.5 Jinyu Bio-technology Recent Developments/Updates

6.11 Shanghai Shen Lian Biomedical

6.11.1 Shanghai Shen Lian Biomedical Company Information

6.11.2 Shanghai Shen Lian Biomedical Description and Business Overview

6.11.3 Shanghai Shen Lian Biomedical mRNA Vaccines for Animals Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Shanghai Shen Lian Biomedical mRNA Vaccines for Animals Product Portfolio

6.11.5 Shanghai Shen Lian Biomedical Recent Developments/Updates

6.12 Suzhou Kerui Meide Biomedical Technology

6.12.1 Suzhou Kerui Meide Biomedical Technology Company Information

6.12.2 Suzhou Kerui Meide Biomedical Technology Description and Business Overview

6.12.3 Suzhou Kerui Meide Biomedical Technology mRNA Vaccines for Animals Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Suzhou Kerui Meide Biomedical Technology mRNA Vaccines for Animals Product Portfolio

6.12.5 Suzhou Kerui Meide Biomedical Technology Recent Developments/Updates

6.13 Shanghai Rnacure Biopharma

6.13.1 Shanghai Rnacure Biopharma Company Information

6.13.2 Shanghai Rnacure Biopharma Description and Business Overview

6.13.3 Shanghai Rnacure Biopharma mRNA Vaccines for Animals Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Shanghai Rnacure Biopharma mRNA Vaccines for Animals Product Portfolio

6.13.5 Shanghai Rnacure Biopharma Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 mRNA Vaccines for Animals Industry Chain Analysis

7.2 mRNA Vaccines for Animals Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 mRNA Vaccines for Animals Production Mode & Process Analysis

7.4 mRNA Vaccines for Animals Sales and Marketing

7.4.1 mRNA Vaccines for Animals Sales Channels

7.4.2 mRNA Vaccines for Animals Distributors

7.5 mRNA Vaccines for Animals Customer Analysis

8 mRNA Vaccines for Animals Market Dynamics

8.1 mRNA Vaccines for Animals Industry Trends

8.2 mRNA Vaccines for Animals Market Drivers

8.3 mRNA Vaccines for Animals Market Challenges

8.4 mRNA Vaccines for Animals Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Shanghai Shen Lian Biomedical

Suzhou Kerui Meide Biomedical Technology

Shanghai Rnacure Biopharma

List of Tables

Table 1. Global mRNA Vaccines for Animals Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global mRNA Vaccines for Animals Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global mRNA Vaccines for Animals Market Competitive Situation by Manufacturers in 2024

Table 4. Global mRNA Vaccines for Animals Sales (K Dose) of Key Manufacturers (2020-2025)

Table 5. Global mRNA Vaccines for Animals Sales Market Share by Manufacturers (2020-2025)

Table 6. Global mRNA Vaccines for Animals Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global mRNA Vaccines for Animals Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market mRNA Vaccines for Animals Average Price (US$/Dose) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of mRNA Vaccines for Animals, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of mRNA Vaccines for Animals, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of mRNA Vaccines for Animals, Product Type & Application

Table 12. Global Key Manufacturers of mRNA Vaccines for Animals, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global mRNA Vaccines for Animals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccines for Animals as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global mRNA Vaccines for Animals Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global mRNA Vaccines for Animals Sales by Region (2020-2025) & (K Dose)

Table 18. Global mRNA Vaccines for Animals Sales Market Share by Region (2020-2025)

Table 19. Global mRNA Vaccines for Animals Sales by Region (2026-2031) & (K Dose)

Table 20. Global mRNA Vaccines for Animals Sales Market Share by Region (2026-2031)

Table 21. Global mRNA Vaccines for Animals Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global mRNA Vaccines for Animals Revenue Market Share by Region (2020-2025)

Table 23. Global mRNA Vaccines for Animals Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global mRNA Vaccines for Animals Revenue Market Share by Region (2026-2031)

Table 25. North America mRNA Vaccines for Animals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America mRNA Vaccines for Animals Sales by Country (2020-2025) & (K Dose)

Table 27. North America mRNA Vaccines for Animals Sales by Country (2026-2031) & (K Dose)

Table 28. North America mRNA Vaccines for Animals Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America mRNA Vaccines for Animals Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe mRNA Vaccines for Animals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe mRNA Vaccines for Animals Sales by Country (2020-2025) & (K Dose)

Table 32. Europe mRNA Vaccines for Animals Sales by Country (2026-2031) & (K Dose)

Table 33. Europe mRNA Vaccines for Animals Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe mRNA Vaccines for Animals Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific mRNA Vaccines for Animals Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific mRNA Vaccines for Animals Sales by Region (2020-2025) & (K Dose)

Table 37. Asia Pacific mRNA Vaccines for Animals Sales by Region (2026-2031) & (K Dose)

Table 38. Asia Pacific mRNA Vaccines for Animals Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific mRNA Vaccines for Animals Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America mRNA Vaccines for Animals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America mRNA Vaccines for Animals Sales by Country (2020-2025) & (K Dose)

Table 42. Latin America mRNA Vaccines for Animals Sales by Country (2026-2031) & (K Dose)

Table 43. Latin America mRNA Vaccines for Animals Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America mRNA Vaccines for Animals Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa mRNA Vaccines for Animals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa mRNA Vaccines for Animals Sales by Country (2020-2025) & (K Dose)

Table 47. Middle East and Africa mRNA Vaccines for Animals Sales by Country (2026-2031) & (K Dose)

Table 48. Middle East and Africa mRNA Vaccines for Animals Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa mRNA Vaccines for Animals Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global mRNA Vaccines for Animals Sales (K Dose) by Type (2020-2025)

Table 51. Global mRNA Vaccines for Animals Sales (K Dose) by Type (2026-2031)

Table 52. Global mRNA Vaccines for Animals Sales Market Share by Type (2020-2025)

Table 53. Global mRNA Vaccines for Animals Sales Market Share by Type (2026-2031)

Table 54. Global mRNA Vaccines for Animals Revenue (US$ Million) by Type (2020-2025)

Table 55. Global mRNA Vaccines for Animals Revenue (US$ Million) by Type (2026-2031)

Table 56. Global mRNA Vaccines for Animals Revenue Market Share by Type (2020-2025)

Table 57. Global mRNA Vaccines for Animals Revenue Market Share by Type (2026-2031)

Table 58. Global mRNA Vaccines for Animals Price (US$/Dose) by Type (2020-2025)

Table 59. Global mRNA Vaccines for Animals Price (US$/Dose) by Type (2026-2031)

Table 60. Global mRNA Vaccines for Animals Sales (K Dose) by Application (2020-2025)

Table 61. Global mRNA Vaccines for Animals Sales (K Dose) by Application (2026-2031)

Table 62. Global mRNA Vaccines for Animals Sales Market Share by Application (2020-2025)

Table 63. Global mRNA Vaccines for Animals Sales Market Share by Application (2026-2031)

Table 64. Global mRNA Vaccines for Animals Revenue (US$ Million) by Application (2020-2025)

Table 65. Global mRNA Vaccines for Animals Revenue (US$ Million) by Application (2026-2031)

Table 66. Global mRNA Vaccines for Animals Revenue Market Share by Application (2020-2025)

Table 67. Global mRNA Vaccines for Animals Revenue Market Share by Application (2026-2031)

Table 68. Global mRNA Vaccines for Animals Price (US$/Dose) by Application (2020-2025)

Table 69. Global mRNA Vaccines for Animals Price (US$/Dose) by Application (2026-2031)

Table 70. Ceva Animal Health Company Information

Table 71. Ceva Animal Health Description and Business Overview

Table 72. Ceva Animal Health mRNA Vaccines for Animals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 73. Ceva Animal Health mRNA Vaccines for Animals Product

Table 74. Ceva Animal Health Recent Developments/Updates

Table 75. Merck Animal Health Company Information

Table 76. Merck Animal Health Description and Business Overview

Table 77. Merck Animal Health mRNA Vaccines for Animals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 78. Merck Animal Health mRNA Vaccines for Animals Product

Table 79. Merck Animal Health Recent Developments/Updates

Table 80. Areterna Company Information

Table 81. Areterna Description and Business Overview

Table 82. Areterna mRNA Vaccines for Animals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 83. Areterna mRNA Vaccines for Animals Product

Table 84. Areterna Recent Developments/Updates

Table 85. Bayer Company Information

Table 86. Bayer Description and Business Overview

Table 87. Bayer mRNA Vaccines for Animals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 88. Bayer mRNA Vaccines for Animals Product

Table 89. Bayer Recent Developments/Updates

Table 90. BioNTech Company Information

Table 91. BioNTech Description and Business Overview

Table 92. BioNTech mRNA Vaccines for Animals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 93. BioNTech mRNA Vaccines for Animals Product

Table 94. BioNTech Recent Developments/Updates

Table 95. Genvax Technologies Company Information

Table 96. Genvax Technologies Description and Business Overview

Table 97. Genvax Technologies mRNA Vaccines for Animals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 98. Genvax Technologies mRNA Vaccines for Animals Product

Table 99. Genvax Technologies Recent Developments/Updates

Table 100. BioVenic Company Information

Table 101. BioVenic Description and Business Overview

Table 102. BioVenic mRNA Vaccines for Animals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 103. BioVenic mRNA Vaccines for Animals Product

Table 104. BioVenic Recent Developments/Updates

Table 105. Moderna Company Information

Table 106. Moderna Description and Business Overview

Table 107. Moderna mRNA Vaccines for Animals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 108. Moderna mRNA Vaccines for Animals Product

Table 109. Moderna Recent Developments/Updates

Table 110. Ruipu Biotechnology Company Information

Table 111. Ruipu Biotechnology Description and Business Overview

Table 112. Ruipu Biotechnology mRNA Vaccines for Animals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 113. Ruipu Biotechnology mRNA Vaccines for Animals Product

Table 114. Ruipu Biotechnology Recent Developments/Updates

Table 115. Jinyu Bio-technology Company Information

Table 116. Jinyu Bio-technology Description and Business Overview

Table 117. Jinyu Bio-technology mRNA Vaccines for Animals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 118. Jinyu Bio-technology mRNA Vaccines for Animals Product

Table 119. Jinyu Bio-technology Recent Developments/Updates

Table 120. Shanghai Shen Lian Biomedical Company Information

Table 121. Shanghai Shen Lian Biomedical Description and Business Overview

Table 122. Shanghai Shen Lian Biomedical mRNA Vaccines for Animals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 123. Shanghai Shen Lian Biomedical mRNA Vaccines for Animals Product

Table 124. Shanghai Shen Lian Biomedical Recent Developments/Updates

Table 125. Suzhou Kerui Meide Biomedical Technology Company Information

Table 126. Suzhou Kerui Meide Biomedical Technology Description and Business Overview

Table 127. Suzhou Kerui Meide Biomedical Technology mRNA Vaccines for Animals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 128. Suzhou Kerui Meide Biomedical Technology mRNA Vaccines for Animals Product

Table 129. Suzhou Kerui Meide Biomedical Technology Recent Developments/Updates

Table 130. Shanghai Rnacure Biopharma Company Information

Table 131. Shanghai Rnacure Biopharma Description and Business Overview

Table 132. Shanghai Rnacure Biopharma mRNA Vaccines for Animals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 133. Shanghai Rnacure Biopharma mRNA Vaccines for Animals Product

Table 134. Shanghai Rnacure Biopharma Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. mRNA Vaccines for Animals Distributors List

Table 138. mRNA Vaccines for Animals Customers List

Table 139. mRNA Vaccines for Animals Market Trends

Table 140. mRNA Vaccines for Animals Market Drivers

Table 141. mRNA Vaccines for Animals Market Challenges

Table 142. mRNA Vaccines for Animals Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

Table 146. Authors List of This Report

List of Figures

Figure 1. Product Picture of mRNA Vaccines for Animals

Figure 2. Global mRNA Vaccines for Animals Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global mRNA Vaccines for Animals Market Share by Type: 2024 & 2031

Figure 4. Injectable Drug Administration Product Picture

Figure 5. Non-invasive Drug Administration Product Picture

Figure 6. Global mRNA Vaccines for Animals Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global mRNA Vaccines for Animals Market Share by Application: 2024 & 2031

Figure 8. for Poultry

Figure 9. for Livestock

Figure 10. Others

Figure 11. Global mRNA Vaccines for Animals Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global mRNA Vaccines for Animals Market Size (2020-2031) & (US$ Million)

Figure 13. Global mRNA Vaccines for Animals Sales (2020-2031) & (K Dose)

Figure 14. Global mRNA Vaccines for Animals Average Price (US$/Dose) & (2020-2031)

Figure 15. mRNA Vaccines for Animals Report Years Considered

Figure 16. mRNA Vaccines for Animals Sales Share by Manufacturers in 2024

Figure 17. Global mRNA Vaccines for Animals Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest mRNA Vaccines for Animals Players: Market Share by Revenue in mRNA Vaccines for Animals in 2024

Figure 19. mRNA Vaccines for Animals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global mRNA Vaccines for Animals Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America mRNA Vaccines for Animals Sales Market Share by Country (2020-2031)

Figure 22. North America mRNA Vaccines for Animals Revenue Market Share by Country (2020-2031)

Figure 23. United States mRNA Vaccines for Animals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada mRNA Vaccines for Animals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe mRNA Vaccines for Animals Sales Market Share by Country (2020-2031)

Figure 26. Europe mRNA Vaccines for Animals Revenue Market Share by Country (2020-2031)

Figure 27. Germany mRNA Vaccines for Animals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France mRNA Vaccines for Animals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. mRNA Vaccines for Animals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy mRNA Vaccines for Animals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia mRNA Vaccines for Animals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific mRNA Vaccines for Animals Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific mRNA Vaccines for Animals Revenue Market Share by Region (2020-2031)

Figure 34. China mRNA Vaccines for Animals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan mRNA Vaccines for Animals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea mRNA Vaccines for Animals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India mRNA Vaccines for Animals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia mRNA Vaccines for Animals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan mRNA Vaccines for Animals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia mRNA Vaccines for Animals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America mRNA Vaccines for Animals Sales Market Share by Country (2020-2031)

Figure 42. Latin America mRNA Vaccines for Animals Revenue Market Share by Country (2020-2031)

Figure 43. Mexico mRNA Vaccines for Animals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil mRNA Vaccines for Animals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina mRNA Vaccines for Animals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Colombia mRNA Vaccines for Animals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa mRNA Vaccines for Animals Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa mRNA Vaccines for Animals Revenue Market Share by Country (2020-2031)

Figure 49. Turkey mRNA Vaccines for Animals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia mRNA Vaccines for Animals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE mRNA Vaccines for Animals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of mRNA Vaccines for Animals by Type (2020-2031)

Figure 53. Global Revenue Market Share of mRNA Vaccines for Animals by Type (2020-2031)

Figure 54. Global mRNA Vaccines for Animals Price (US$/Dose) by Type (2020-2031)

Figure 55. Global Sales Market Share of mRNA Vaccines for Animals by Application (2020-2031)

Figure 56. Global Revenue Market Share of mRNA Vaccines for Animals by Application (2020-2031)

Figure 57. Global mRNA Vaccines for Animals Price (US$/Dose) by Application (2020-2031)

Figure 58. mRNA Vaccines for Animals Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Livestock mRNA Vaccines Market Research Report 2025

Messenger RNA Vaccines and Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Livestock Animal Vaccination Market Research Report 2025

Veterinary Vaccine Market

Global Livestock Vaccines Market Research Report 2025

Global mRNA Vaccines Therapeutics Market Research Report 2024

Global Livestock Animal Vaccines Market Research Report 2024

Global Veterinary Biological Vaccines Market Research Report 2025

Global mRNA Vaccine And Therapeutics Market Insights Forecast to 2030

Global Veterinary Vaccination Market Research Report 2025

Global mRNA Therapy Market Research Report 2024

mRNA Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Farm Animal Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccines for Livestock Farming Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

mRNA Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non Replicating mRNA Vaccine Market Research Report 2025

Global Personalized mRNA Cancer Vaccine Therapy Market Research Report 2025

Global Synthetic Peptide Vaccines for Veterinary Use Market Research Report 2025

Global mRNA Cancer Vaccines and Therapeutics Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions